This inventor holds 1 USPTO granted patent. Top assignee: Avecia Biologics Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: **David John Evans: Innovator in Peptide Synthesis**
Introduction
David John Evans, an accomplished inventor based in Manchester, GB, has made a significant contribution to the field of peptide chemistry. With a singular patent to his name, Evans’ work focuses on the innovative synthesis of peptide amides, showcasing his expertise and dedication to advancing biochemistry.
Latest Patents
Evans holds a patent for a pioneering method entitled “Process for the synthesis of peptides amides by side-chain attachment to a solid phase.” This patented process involves the solid-phase synthesis of a peptide amide, achieved through the attachment of an α-nitrogen protected Cα-carboxamide amino acid to a solid support by its side chain. Following the removal of the α-nitrogen protecting group, a peptide chain is assembled and ultimately cleaved from the solid support. Moreover, this patent includes novel amino acid analogues, peptide amides, and solid-phase supports, highlighting Evans’ innovative approach in the domain of peptide synthesis.
Career Highlights
Throughout his career, David John Evans has worked at Avecia Biologics Limited, a company recognized for its contributions to biologics development and manufacturing. His work with the company has allowed him to apply his knowledge and skills in a practical setting, leading to advancements in peptide synthesis technology.
Collaborations
During his tenure at Avecia Biologics Limited, Evans has collaborated with notable colleagues, including Dean Steven Anthony Simpkin and Donald Alfred Wellings. These collaborations have fostered a creative environment where innovative ideas can flourish, ultimately contributing to the successful development of biotechnological solutions.
Conclusion
David John Evans represents a vital force in the field of peptide synthesis. Through his innovative patented methods and valuable collaborations, he continues to play a crucial role in advancing biochemistry and biotechnology. His work not only enhances our understanding of peptide amides but also paves the way for future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile